Abstract
Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
Keywords: Carotid artery stenosis, statins, antiplatelet agents, hypertension, risk factors, diagnosis
Current Vascular Pharmacology
Title: ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis
Volume: 8 Issue: 5
Author(s): Christos D. Liapis, Sir Peter F. Bell, Dimitri P. Mikhailidis, Juhani Sivenius, Andrew Nicolaides, Jose Fernandes e Fernandes, Giorgio Biasi, Lars Norgren and ESVS Guidelines Collaborators
Affiliation:
Keywords: Carotid artery stenosis, statins, antiplatelet agents, hypertension, risk factors, diagnosis
Abstract: Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
Export Options
About this article
Cite this article as:
D. Liapis Christos, Peter F. Bell Sir, P. Mikhailidis Dimitri, Sivenius Juhani, Nicolaides Andrew, Fernandes e Fernandes Jose, Biasi Giorgio, Norgren Lars and Guidelines Collaborators ESVS, ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis, Current Vascular Pharmacology 2010; 8 (5) . https://dx.doi.org/10.2174/157016110792006888
DOI https://dx.doi.org/10.2174/157016110792006888 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Endothelins and Nitric Oxide: Vasoactive Modulators of Carotid Body Chemoreception
Current Neurovascular Research Medical Treatment of Uterine Arteriovenous Malformations: A Case Report
Current Women`s Health Reviews Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
Current Pharmaceutical Design Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery
Current Drug Targets Anatomical Approach to Clinical Problems of Popliteal Fossa
Current Rheumatology Reviews Antiepileptic Treatment Strategy in Vascular Malformations
Current Pharmaceutical Design Genetic Polymorphism of LDLR (rs688) is Associated with Primary Intracerebral Hemorrhage
Current Neurovascular Research Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Prophylactic Neuroprotection
Current Drug Targets Meet Our Section Editor
Central Nervous System Agents in Medicinal Chemistry Management of Hypertension in the Acute Phase of Stroke
Current Hypertension Reviews Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Current Pharmaceutical Design Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science Pathophysiology of the Vascular Wall and its Relevance for Cerebrovascular Disorders in Aged Rodents
Current Neurovascular Research Syncope in a Child with Pulmonary Hypertension and Positive Gene Tests for Hereditary Hemorrhagic Telangiectasia and Long QT Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Current Pharmaceutical Design